FindTrial
Sign In

Flow-MRD

DIAGNOSTIC_TEST2 trials

Sponsors

Nanfang Hospital, Southern Medical University

Conditions

Adult Acute Lymphoblastic LeukemiaAdult Lymphoblastic LymphomaLeukemiaLeukemia, AcuteLeukemia, LymphoblasticLeukemia, T CellLymphoblastic LeukemiaLymphoblastic Lymphoma

Phase 2

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL
NCT03553238
Nanfang Hospital, Southern Medical UniversityLeukemia, Acute, Leukemia, Lymphoblastic, Leukemia, T Cell
Start: 2016-02-14End: 2020-08-30Target: 70Updated: 2018-06-12
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
NCT03564704
Nanfang Hospital, Southern Medical UniversityAdult Acute Lymphoblastic Leukemia, Adult Lymphoblastic Lymphoma, Leukemia +5
Start: 2016-02-14End: 2021-05-30Target: 80Updated: 2018-06-21

Related Papers

Intensified pegylated-asparaginase in consolidation therapy improved outcome of allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia.
2025-12-23
Tucidinostat Plus Pediatric-Inspired Chemotherapy As First-Line Therapy for Newly Diagnosed ETP-ALL/Lbl: An Open-Label, Single-Arm, Phase 2 Trial
Blood2024-11-05
Tucidinostat plus pediatric-inspired chemotherapy for newly diagnosed adult ETP-ALL/LBL: a single-arm, phase 2 trial.
2024-10-282 citations
PF181 PEDIATRIC-INSPIRED REGIMEN PLUS HDACI CHIDAMIDE YIELDED PROMISING RESPONSE IN PH-LIKE AND ETP ACUTE LYMPHOBLASTIC LEUKEMIA
HemaSphere2019-06-01
A Novel Oral Histone Deacetylase Inhibitor Chidamide Is Highly Effective and Well-Tolerated in Adult Early T-Cell Precursor and Ph-like Acute Lymphoblastic Leukemia
Blood2018-11-296 citations